Lab Test Fees Are Sticky Widget in Final MDUFA Negotiations

A A
The final sticking point in FDA-industry MDUFA III negotiations centered on disagreement over regulation of laboratory-developed tests (LDTs), newly released meeting minutes show.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00